P Chamberland - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

P Chamberland

Showing results (51-60 of 53) with videos related to

Pageof 6

Sort By:

You have reached the last page of results.This site can display upto 53 results.

Diabetes|May 28, 2011

Efficacy of metreleptin in obese patients with type 2 diabetes: cellular and molecular pathways underlying leptin toleranceHyun-Seuk Moon, Giuseppe Matarese, Aoife M Brennan, et al.

International Journal of Obesity (2005)|June 12, 2014

Circulating irisin levels and coronary heart disease: association with future acute coronary syndrome and major adverse cardiovascular eventsK N Aronis, M Moreno, S A Polyzos, et al.

Medical Physics|July 20, 2017

A generic TG-186 shielded applicator for commissioning model-based dose calculation algorithms for high-dose-rate <sup>192</sup> Ir brachytherapyYunzhi Ma, Javier Vijande, Facundo Ballester, et al.

Pageof 6

Search research articles

Showing results (51-60 of 53) with videos related to

Sort By:

Pageof 6

You have reached the last page of results.This site can display upto 53 results.

Diabetes|May 28, 2011

Efficacy of metreleptin in obese patients with type 2 diabetes: cellular and molecular pathways underlying leptin toleranceHyun-Seuk Moon, Giuseppe Matarese, Aoife M Brennan, et al.

International Journal of Obesity (2005)|June 12, 2014

Circulating irisin levels and coronary heart disease: association with future acute coronary syndrome and major adverse cardiovascular eventsK N Aronis, M Moreno, S A Polyzos, et al.

Medical Physics|July 20, 2017

A generic TG-186 shielded applicator for commissioning model-based dose calculation algorithms for high-dose-rate <sup>192</sup> Ir brachytherapyYunzhi Ma, Javier Vijande, Facundo Ballester, et al.

Pageof 6